Pharma CEO gave herself an $18 million raise after hiking EpiPen prices
The pharmaceutical company that cornered the market on the life-saving EpiPen and dramatically increased its price also jacked up the pay of top executives. Between 2007, when Mylan acquired the patent for the EpiPen,...